As of Apr 25
| +0.03 / +2.21%|
The 1 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +151.80% increase from the last price of 1.39.
The current consensus among 5 polled investment analysts is to Hold stock in Arena Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.